Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Nuvectis Pharma stock

Learn how to easily invest in Nuvectis Pharma stock.

Nuvectis Pharma Inc is a biotechnology business based in the US. Nuvectis Pharma shares (NVCT) are listed on the NASDAQ and all prices are listed in US Dollars. Nuvectis Pharma employs 8 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Nuvectis Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NVCT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Nuvectis Pharma stock price (NASDAQ: NVCT)

Use our graph to track the performance of NVCT stocks over time.

Nuvectis Pharma shares at a glance

Information last updated 2022-06-30.
Latest market close$13.00
52-week range$3.08 - $20.92
50-day moving average $13.06
200-day moving average $10.27
Wall St. target price$20.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.83

Buy Nuvectis Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Nuvectis Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nuvectis Pharma price performance over time

Historical closes compared with the close of $13 from 2022-07-06

1 week (2022-06-30) 16.07%
1 month (2022-06-07) 7.79%
3 months (2022-04-07) 38.89%
6 months (2022-01-03) N/A
1 year (2021-07-03) N/A
2 years (2020-07-03) N/A
3 years (2019-07-03) N/A
5 years (2017-07-03) N/A

Nuvectis Pharma financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM -609.75%
Profit margin 0%
Book value $1.15
Market capitalisation $150.6 million

TTM: trailing 12 months

Nuvectis Pharma share dividends

We're not expecting Nuvectis Pharma to pay a dividend over the next 12 months.

You may also wish to consider:

Nuvectis Pharma overview

Nuvectis Pharma, Inc. , a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey. .

Frequently asked questions

What percentage of Nuvectis Pharma is owned by insiders or institutions?
Currently 59.751% of Nuvectis Pharma shares are held by insiders and 15.925% by institutions.
How many people work for Nuvectis Pharma?
Latest data suggests 8 work at Nuvectis Pharma.
When does the fiscal year end for Nuvectis Pharma?
Nuvectis Pharma's fiscal year ends in December.
Where is Nuvectis Pharma based?
Nuvectis Pharma's address is: 1 Bridge Plaza, Fort Lee, NJ, United States, 07024
What is Nuvectis Pharma's ISIN number?
Nuvectis Pharma's international securities identification number is: US67080T1088

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site